Histogen Inc logo

HSTO - Histogen Inc News Story

$0.71 -0.0  -3.0%

Last Trade - 27/10/21

Sector
Healthcare
Size
Micro Cap
Market Cap £22.2m
Enterprise Value £4.68m
Revenue £1.02m
Position in Universe 6384th / 7275

Histogen Inc reports results for the quarter ended in June - Earnings Summary

Wed 11th August, 2021 10:15pm
* Histogen Inc  HSTO.OQ  reported a quarterly adjusted loss
of 10 cents​​ per share for the quarter ended in June. The lone
analyst forecast for the quarter was for a loss of 17 cents per
share.
* Revenue was $5.00 thousand​;  analysts expected zero. 
* Histogen Inc's reported EPS for the quarter was a loss of 10
cents​.
* The mean earnings estimate of analysts had fallen by
about 13.3% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Histogen Inc shares had fallen by 20.5% this quarter and
gained 14.3% so far this year.
* The company reported a quarterly loss of $3.7 million.
* Wall Street's median 12-month price target for Histogen Inc is
$4.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 11 at 09:15 p.m.  ​All
figures in US dollars unless otherwise stated
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.